Prana Selected to Present at Windhover's Therapeutic Area Partnerships Conference by Independent Expert
November 11, 2009 10:30 ET
|
Prana Biotechnology Ltd.
NEW YORK, Nov. 11, 2009 (GLOBE NEWSWIRE) -- Prana Biotechnology (Nasdaq:PRAN) (ASX:PBT) today announced that Dr. Rudy Tanzi, Scientific Advisory Board will present at the 2009 Windhover's Therapeutic...
Prana Secures $6 Million Additional Financing
September 09, 2009 09:17 ET
|
Prana Biotechnology Ltd.
NEW YORK, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Prana Biotechnology (ASX:PBT) (Nasdaq:PRAN) today announced that it has reached an agreement to raise $6 million (Australian) to support its R&D...
Prana Biotechnology to Present At the Rodman and Renshaw Annual Global Investment Conference
September 02, 2009 08:30 ET
|
Prana Biotechnology Ltd.
NEW YORK, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Prana Biotechnology (ASX:PBT) (Nasdaq:PRAN) today announced that the Company's co-founders Geoffrey Kempler, Chairman and Chief Executive Officer, and Dr....
Prana Allowed Key Patent for PBT2 in the United States
August 12, 2009 10:15 ET
|
Prana Biotechnology Ltd.
NEW YORK, Aug. 12, 2009 (GLOBE NEWSWIRE) -- Prana Biotechnology (ASX:PBT) (Nasdaq:PRAN) today announced that it has received a Notice of Allowance from the United States Patent and Trade Mark Office...
Prana is Granted Key Patent by European Patent Office
August 05, 2009 08:31 ET
|
Prana Biotechnology Ltd.
NEW YORK, Aug. 5, 2009 (GLOBE NEWSWIRE) -- Prana Biotechnology (Nasdaq:PRAN) (ASX:PBT) today announced that it has secured a key patent protecting its clinical drug asset PBT2, with the European...
Prana's Head of Research Presents New Efficacy Data in Hot Topics Session At ICAD
July 15, 2009 10:51 ET
|
Prana Biotechnology Ltd.
* New data indicates PBT2 benefits not only Alzheimer's disease
patients, but also could treat the cognitive loss commonly
associated with the normal ageing process.
* PBT2 lowers amyloid...